LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
LyGenesis has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
LyGenesis's investors include Juvenescence, Longevity Vision Fund, Prime Movers Lab.
LyGenesis is headquartered in Pittsburgh, United States.
LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.
LyGenesis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LyGenesis — Funding & Investors." VCBacked, October 24, 2023, https://www.vcbacked.co/company/lygenesis. Accessed October 30, 2026.
VCBacked. (2023). LyGenesis — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/lygenesis
{{cite web |title=LyGenesis — Funding & Investors |url=https://www.vcbacked.co/company/lygenesis |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated